(Bloomberg) -- Life-sciences company Danaher Corp. has stopped pursuing Catalent Inc. after expressing interest in buying the contract manufacturer, according to people familiar with the matter.
Never miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday. Want ...
The Catalent (CTLT) stock move comes after recent speculation that Danaher (NYSE:DHR) may still be interested in a takeover even after a report last Monday that the life-science company ended its ...
Life-sciences company Danaher Corporation (NYSE: DHR) is reportedly no longer considering a takeover of contract manufacturer Catalent Inc (NYSE: CTLT) after expressing interest in buying the ...
Days later, Bloomberg reported that Danaher Corp. was no longer considering a takeover of Catalent, according to people familiar with the situation. Danaher had earlier made overtures to the ...
Never miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday. Want ...
Last month, Bloomberg reported that Danaher had shelved this buyout plan after Catalent announced that it was facing productivity problems and high-than-expected costs at three of its major ...
Pall Corp. (PLL) stock is rising after the company said it will be acquired by Danaher (DHR) for $13.8 billion. Pall Corp. (PLL) stock is rising after the company said it will be acquired by ...
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments ...
